About Genentech We're passionate about finding solutions for people facing the world's most difficult-to-treat conditions. That is why we use cutting-edge science to create and deliver innovative medicines around the globe. To us, science is personal. Making a difference in the lives of millions starts when you make a change in yours. If you’d like to join our team, view our openings at gene.com/careers. Our patient resource center is dedicated to getting patients and caregivers to the right resources. You can reach them at 1 (877) GENENTECH (436-3683) Monday-Friday, 6am-5pm PST or [email protected]. Community Guidelines: 1. We want to foster positive conversation and diverse community around the issues we are passionate about. To that end, we remove profanity, content that contains credible threats or hate speech, content that is aimed at private individuals, personal information meant to harass someone, and repeated unwanted messages. 2. Don’t mention any medicines by name — ours or anyone else’s. Because of the fair balance rules governing our industry, we cannot post any comments that reference any pharmaceutical brand, product, or service. Please do not mention any specific medicines by name, or include any links to third party sites in your comments. 3. This isn’t the place to report or discuss side effects. This site is not intended as a forum for reporting side effects experienced while taking a Genentech product. Instead, you should report any side effects to Genentech Drug Safety at 1-888-835-2555. You can also report side effects of any prescription product directly to the FDA at 1-800-FDA-1088 or by visiting www.FDA.gov/medwatch. 4. Don’t pitch your product or service. Please don't use our page as a place to promote your product or pitch your services. Please also avoid posting links to external sites. We reserve the right to remove any posts that are deemed promotional.

The way we see it, the impossible is not impossible. It’s simply what hasn’t been achieved yet. For more than 30 years, we’ve pursued it, chased it down, tackled it for answers and surrounded it for a way in. We have worked tirelessly to bring forward medicines for life-threatening diseases. Creating Possible drives everything we do. It’s evident in our mission and core values. This is how we built a culture of excellence that is fueled by a passion for improving lives of people around the world. For us, nothing is impossible – because of the people we work with, the communities we stand with and the partners we push forward with. Our ~12,000 employees band together through science, grit, compassion and courage to prove the impossible wrong. At Gilead, the tangible results of your contributions are evident. Where every individual matters. Where all employees can enhance their skills through ongoing development. And where we start every day with one question: “What’s next?” Social Media Guidelines: https://gilead.inc/3t1m7d5

Jazz Pharmaceuticals plc (Nasdaq: JAZZ), is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are focused on developing life-changing medicines for people with serious diseases—often with limited or no options—so they can live their lives more fully. By transforming biopharmaceutical discoveries into novel medicines, we are working to give people around the world the opportunity to redefine what’s possible – to make the “small wins” big again. Founded in 2003 and headquartered in Dublin, Ireland, Jazz Pharmaceuticals has a significant corporate presence in Palo Alto, CA and Philadelphia, PA and in England in London, Oxford and Cambridge, with manufacturing facilities in Ireland, England and Italy. We maintain a highly collaborative culture where employees focus on how they can be successful and accomplish positive results by exemplifying the company’s core values: integrity, collaboration, passion, innovation and the pursuit of excellence. Together, we are experts, analysts, specialists, advocates, scientists and professionals all with diverse backgrounds and perspectives. Working together, we are proud to support patients, innovate and bring new medicines to patients with critical unmet needs. Please see our website at www.jazzpharma.com for more information. For information on recruitment, please visit https://careers.jazzpharma.com/. For guidelines on engaging with Jazz on social media, please visit https://bit.ly/2OaMOuq.

Every Exelixis employee is united in an ambitious cause: to transform science into new treatments that give cancer patients and their families hope for the future. In this pursuit, we know our employees are our most valuable asset. As a diverse, growing team, everyone at Exelixis plays a role in advancing our mission through our innovative drug discovery, development and commercialization efforts. We take pride in our shared purpose, knowing the magnitude of our impact expands with every medicine we create and every form of cancer tumor type we treat. After operating in the challenging biotech sector for nearly three decades, we've evolved into a multi-platform cancer company with a proven track record of resiliency in the face of adversity. The success of our flagship commercial product set us up on our journey to discover and develop next-generation cancer treatments, driven by our relentless pursuit of results for the patients we serve. Cancer is our cause. Make it yours, too. Please see our Community Guidelines: bit.ly/2XXw9w3 For more information about Exelixis, please visit www.exelixis.com, follow @ExelixisInc on Twitter or like Exelixis, Inc. on Facebook.

JSR North America Holdings, Inc. is a privately held corporation operating in the US. Our activities span the North American region, serving global clients in the semiconductor, drug discovery, biopharmaceutical, clinical research and clean energy solutions markets.

Amyris is a vertically integrated, synthetic biology company that creates sustainable, market-ready ingredients utilizing proprietary advanced precision fermentation technology and world-class platforms. Leveraging two decades of experience, Amyris collaborates with companies to co-create innovative ingredients at unprecedented speed and scale. This enables partners to deliver products with differentiated performance that meet sustainability and economic objectives. Its renewable and traceable ingredients are included in over 20,000 products from the world’s top brands, reaching more than 300 million consumers. For more information, please visit http://www.amyris.com.

Garratt-Callahan Company is one of the leading providers of expert industrial water treatment solutions. Offering comprehensive water treatment solutions and expert consulting services backed by 117+ years of experience, we optimize system performance to extend equipment life, reduce health and safety risks, and minimize operating costs. We are guided by our responsibility to provide our customers with unparalleled customer service and effective, dependable water treatment solutions. Garratt-Callahan takes a proactive scientific approach to prevent problems before they occur so that our customers can spend more time running their business and less time trying to fix it. Specialties We utilize the most current, proven technology and treat our customers’ facilities with the same care and conscientiousness that we would with our own. We offer a full range of chemical and equipment solutions, created in our certified laboratory that follows State and Federal EPA standards. We also ensure that our water treatment products are certified in compliance with the international standards of quality of ISO 9001:2015 by NSF-ISR. Our water treatment services include: * Boiler Water Treatment * Cooling Water Treatment * Wastewater Solutions * LAP Certified In-house Laboratory * Water Management Plans * Legionella Mitigation * Secondary Disinfection * Water Treatment Training ASSE/IAPMO/ANSI 12080 Water Safety Training With the global COVID-19 pandemic and virus variants, water safety is even more critical. Our team is trained and certified with the implementation of ASHRAE 188-2018 to minimize the risk of Legionellosis. In 2020, ASHRAE adopted the American Society of Sanitary Engineers (ASSE) 10280. A growing number of our field technicians are certified under the new ASSE 12080 program.

Lumentum (NASDAQ: LITE) is a market-leading designer and manufacturer of innovative optical and photonic products enabling optical networking and laser applications worldwide. Lumentum optical components and subsystems are part of virtually every type of telecom, enterprise, and data center network. Lumentum lasers enable advanced manufacturing techniques and diverse applications including next-generation 3D sensing capabilities. Lumentum is headquartered in San Jose, California with R&D, manufacturing, and sales offices worldwide.

Method Products is part of Lifestyle Brands (the LSB), a growing house of like-minded brands under the SC Johnson umbrella including Method, Mrs. Meyer’s Clean Day, Babyganics and Ecover. Headquartered in San Francisco with additional operations in Chicago and throughout Europe, the LSB is home to 650 employees. Together we act as a force for bold, transformative growth with a focus on delivering positive impact for people and the planet. At the LSB we imagine the world that we want, then set out to create it. We do things differently, because we’re out to make a difference. If you’re into pioneering the future and doing good while doing business, come join us. The LSB is part of SC Johnson, a family-owned company and leading manufacturer of household cleaning, home storage, air care, pest control and shoe care products, as well as professional products. Originally founded in 1886 and headquartered in Wisconsin, U.S.A., SC Johnson and the Lifestyle Brands division are at work for a better world. For career opportunities with SC Johnson Lifestyle Brands, please visit jobs.scjlifestylebrands.com or https://www.linkedin.com/company/scj-lifestyle-brands/ on LinkedIn.

Coherus is a commercial-stage biopharmaceutical company focused on the research, development, and commercialization of innovative immunotherapies to treat cancer and the commercialization of our portfolio of FDA-approved therapeutics. We are building a leading oncology company backed by in-house expertise and an established infrastructure from our diversified portfolio of FDA-approved biosimilar products. If you are interested in joining a highly innovative and exciting company, please visit our careers webpage at http://www.coherus.com/careers/ for a list of career opportunities.

We are Sila—a next generation battery materials company dedicated to accelerating energy transformation for a more sustainable future. Our next-gen anode material is the first significant chemistry improvement to lithium-ion batteries to reach the market in 30 years. Our silicon anode material is a simple drop-in replacement to graphite and significantly boosts the energy density of lithium-ion batteries without compromising performance. Today, Sila science powers innovative consumer electronics. Tomorrow, it will fuel our EV future and the electrification of everything. We work directly with leading consumer electronics and automotive OEMs to help accelerate product roadmaps, and partners with battery manufacturers commercial cell production. Our partners include BMW, Daimler, and ATL. Sila Nano’s first products significantly increase the energy density of state-of-the-art lithium-ion batteries. Our materials are manufacturable economically at scale and are drop-in replacements to existing battery manufacturing processes.

Ascendis Pharma is applying our innovative TransCon technology platform to build a leading, fully integrated biopharmaceutical company focused on making a meaningful difference in patients’ lives. Guided by our core values of patients, science and passion, we utilize our TransCon technology platform to create new and potentially best-in-class therapies. Ascendis Pharma currently has three independent endocrinology rare disease product candidates in clinical development and we're also advancing programs in Oncology and Ophthalmology. Ascendis Pharma is headquartered in Copenhagen, Denmark, with additional offices in Heidelberg, Munich, and Berlin, Germany, Palo Alto and Redwood City, California, and Princeton, New Jersey.